缩写名/全名 |
DRUG SAFETY
DRUG SAFETY |
||||||||||||||||||||||||
ISSN号 | 0114-5916 | ||||||||||||||||||||||||
研究方向 | 医学-毒理学 | ||||||||||||||||||||||||
影响因子 | 2015:3.206, 2016:3.435, 2017:3.585, 2018:3.526, 2019:3.442, | ||||||||||||||||||||||||
出版国家 | NEW ZEALAND | ||||||||||||||||||||||||
出版周期 | Monthly | ||||||||||||||||||||||||
年文章数 | 107 | ||||||||||||||||||||||||
出版年份 | 1990 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||
录用比例 | 一般 | ||||||||||||||||||||||||
投稿链接 | http://www.springer.com/journal/40264/submission | ||||||||||||||||||||||||
投稿官网 | http://link.springer.com/journal/40264 | ||||||||||||||||||||||||
h-index | 115 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0114-5916%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition Author: Minjie Lin, Shuiping Zhao, Li Shen, Danyan Xu Journal: DRUG SAFETY, 2014, Vol.37, 213-224, DOI:10.1007/s40264-014-0147-x DOI |
2. | Dosage Effects of Histamine-2 Receptor Antagonist on the Primary Prophylaxis of Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated Peptic Ulcers: A Retrospective Cohort Study Author: Ying He, Esther W. Chan, Kenneth K. C. Man, Wallis C. Y. Lau, Wai K. Leung, Lai M. Ho, Ian C. K. Wong Journal: DRUG SAFETY, 2014, Vol.37, 711-721, DOI:10.1007/s40264-014-0209-0 DOI |
3. | Pharmacovigilance in China: Current Situation, Successes and Challenges Author: Li Zhang, Lisa Y. L. Wong, Ying He, Ian C. K. Wong Journal: DRUG SAFETY, 2014, Vol.37, 765-770, DOI:10.1007/s40264-014-0222-3 DOI |
4. | Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law Author: Xin Shen, Zheng’an Yuan, Jian Mei, Zurong Zhang, Juntao Guo, Zheyuan Wu, Jie Wu, Haihua Zhang, Jieping Pan, Wenming Huang, Huili Gong, Dong Yuan, Ping Xiao, Yanqin Wang, Yi Shuai, Senlin Lin, Qichao Pan, Tong Zhou, Paul B. Watkins, Fan Wu Journal: DRUG SAFETY, 2013, Vol.37, 43-51, DOI:10.1007/s40264-013-0119-6 DOI |
5. | Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants Author: Haixia Li, Cailian Wang, Shuo Zhang, Sihao Sun, Ruifei Li, Meijuan Zou, Gang Cheng Journal: DRUG SAFETY, 2016, Vol.39, 409-419, DOI:10.1007/s40264-016-0394-0 DOI |
6. | National ADR Monitoring System in China Author: Yongfang Hou, Xinling Li, Guizhi Wu, Xiaofei Ye Journal: DRUG SAFETY, 2016, Vol.39, 1043-1051, DOI:10.1007/s40264-016-0446-5 DOI |
7. | Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature Author: xiongbiao6 Journal: DRUG SAFETY, 2016. |
8. | Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants Author: chenggang63 Journal: DRUG SAFETY, 2016. |
9. | Safety Profile of Atorvastatin 80 mg: A Meta-Analysis of 17 Randomized Controlled Trials in 21,910 Participants Author: chenggang63 Journal: DRUG SAFETY, 2016. |
|
|